Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus
Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus
复制标题
DOI:
10.1177/0961203315585815
复制
发表时间:
2015-10-01
期刊:
影响因子:
2.6
通讯作者:
Tam, L. S.
中科院分区:
文献类型:
--
作者:
Cai, Z.;Wong, C. K.;Tam, L. S.
Objective This study characterizes an IL-35-mediated regulatory role in patients with systemic lupus erythematosus (SLE).Methods Plasma of SLE patients and healthy controls (HCs) was analyzed for the concentrations of IL-35 and soluble gp130 by using ELISA. mRNA expression of IL-35 subunit (p35 and EBI3) and its receptor (gp130 and IL-12R2) in peripheral blood mononuclear cells (PBMCs) was assessed by RT-qPCR. Flow cytometry was performed to evaluate the number of CD4(+)CD25(high)CD127(-)Treg cells and the expression of IL-35 receptor on the CD4+ helper (Th) cells and CD19+ B cells. Plasma collected from SLE patients and HCs was assayed for cytokine and chemokine expression by Luminex multiplex assay.Results Plasma IL-35 and soluble gp130 levels positively correlated with each other and were significantly higher in patients with severe SLE compared with HCs. Significantly higher levels of inflammatory cytokines/chemokines CCL2, CXCL8, IL-6, interferon (IFN)-, IL-10 and IL-17A were observed in plasma of SLE patients than HCs. mRNA levels of IL-35 and its receptor were significantly positively correlated in PBMCs from SLE patients and their levels were higher in SLE than HCs. The increase significantly correlated with changes in SLE Disease Activity Index (SLEDAI) (all p